All stories tagged :

People

Hyaluronic Acid Based Dermal Fillers Market Analysis Report 2025: Influencers Normalize...

admin
People

Bleaching Clay Market to surpass USD 2.2 Billion by 2032, Says...

admin
People

Thailand Behavioural Trends , Purchase and Consumption Habits Report 2024

admin
People

Apparel Group Launches Exciting ‘Summer-Time’ Campaign 2024 Featuring More than 36...

admin
People

Toll Brothers Opens Newest Collection of Luxury Homes in Griffith Lakes...

admin
People

Increasing Adoption of Non-Invasive Aesthetic Procedures & Wellness Services Propels the...

admin
People

La Dolce Vita Emphasizes Water Safety Near Crab Island

admin
People

Cosmetic Chemicals Market Size Expected to Reach USD 49.48 Billion by...

admin
People

Marine Functional Ingredients Market at a CAGR of 8.6% during the...

admin
People

DANDY® CELERY PARTNERS WITH THE PRODUCE MOMS TO REVIVE TRADITION WITH...

admin
People

Safe and Secure Locksmith Launch Enhanced Emergency Locksmith Services in Vancouver

admin

Featured

Pr Newswire

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a...

admin
Pr Newswire

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate...

admin
Pr Newswire

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001...

admin
Pr Newswire

aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis

admin
admin

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a...

ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing...